EBS Begins Commercialization Of Its NEXT WAVE™ Brain Stimulation Device Designed To Expand The Visual Field Of Patients With Impaired Vision Caused, For Example, By Optic Nerve Damage

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BERLIN--(BUSINESS WIRE)--EBS Technologies (“EBS”) announced today that University Medical Center Hamburg-Eppendorf is now offering the use of the EBS NEXT WAVE™ brain stimulation device designed to expand the visual field of patients with impaired vision caused by, for example, optic nerve damage.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC